keyword
https://read.qxmd.com/read/38631708/preclinical-evaluation-and-first-in-dog-clinical-trials-of-pbmc-expanded-natural-killer-cells-for-adoptive-immunotherapy-in-dogs-with-cancer
#21
JOURNAL ARTICLE
Aryana M Razmara, Lauren E Farley, Rayna M Harris, Sean J Judge, Marshall Lammers, Khurshid R Iranpur, Eric G Johnson, Cordelia Dunai, William J Murphy, C Titus Brown, Robert B Rebhun, Michael S Kent, Robert J Canter
BACKGROUND: Natural killer (NK) cells are cytotoxic cells capable of recognizing heterogeneous cancer targets without prior sensitization, making them promising prospects for use in cellular immunotherapy. Companion dogs develop spontaneous cancers in the context of an intact immune system, representing a valid cancer immunotherapy model. Previously, CD5 depletion of peripheral blood mononuclear cells (PBMCs) was used in dogs to isolate a CD5dim -expressing NK subset prior to co-culture with an irradiated feeder line, but this can limit the yield of the final NK product...
April 16, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38630921/the-relationship-of-body-mass-index-on-patient-reported-outcomes-after-platelet-rich-plasma-versus-microfragmented-adipose-tissue-for-knee-osteoarthritis-a-secondary-analysis-of-a-randomized-controlled-trial
#22
JOURNAL ARTICLE
Michael Baria, Reshma George, Tyler Barker, David Flanigan, Christopher Kaeding, Robert Magnussen
OBJECTIVE: Body mass index (BMI) is known to contribute to outcomes for patients with knee OA. Furthermore, BMI influences the protein expression of orthobiologic treatments like platelet-rich plasma (PRP) and microfragmented adipose tissue (MFAT). We performed a secondary analysis of the association of BMI with PROs for patients with knee OA who received either PRP or MFAT injections. METHODS: Seventy-one patients with knee OA were randomized to receive a single ultrasound-guided injection of PRP or MFAT...
April 1, 2024: American Journal of Physical Medicine & Rehabilitation
https://read.qxmd.com/read/38630302/invivo-generated-autologous-plasmin-enzyme-assisted-vitrectomy-partial-circumferential-oral-retinotomy-silicone-oil-injection-in-patients-with-chronic-retinal-detachment-without-posterior-vitreous-detachment
#23
JOURNAL ARTICLE
Cengiz Aras, Fevzi Senturk, Sevil Karaman Erdur, Mahmut Dogramaci, Mehmet Selim Kocabora, Ali Demircan, Yunus Emre Budak
PURPOSE: To report the results of invivo generated autologous plasmin enzyme(IVAP) assisted vitrectomy, partial circumferential-oral retinotomy and silicone oil injection for surgical treatment of patients with chronic retinal detachment without posterior vitreous detachment(PVD). METHODS: Study was performed in retrospective, comparative manner. A total of 16 consecutive eyes with chronic retinal detachment who had intravitreal injection of 50 µgr of t-PA and 0...
April 17, 2024: Graefe's Archive for Clinical and Experimental Ophthalmology
https://read.qxmd.com/read/38630129/monocyte-to-platelets-ratio-mpr-at-diagnosis-is-associated-with-inferior-progression-free-survival-in-patients-with-mantle-cell-lymphoma-a-multi-center-real-life-survey
#24
JOURNAL ARTICLE
Andrea Duminuco, Alessandra Romano, Isacco Ferrarini, Gabriella Santuccio, Annalisa Chiarenza, Amalia Figuera, Laura Anastasia Caruso, Giovanna Motta, Giuseppe Alberto Palumbo, Carlo Mogno, Alessia Moioli, Francesco Di Raimondo, Carlo Visco
Mantle cell lymphoma (MCL) pathogenesis is strongly related to the role of the tumor immune microenvironment (TIME) in which MCL cells proliferate. TIME cells can produce growth signals influencing MCL cells' survival and exert an antitumoral immune response suppression. The activity of TIME cells might be mirrored by some ratios of peripheral blood cell subpopulations, such as the monocyte-to-platelet ratio (MPR). We reviewed the clinical features of 165 consecutive MCL patients newly diagnosed and not eligible for autologous stem cell transplantation (both for age or comorbidities) who accessed two Italian Centers between 2006 and 2020...
April 17, 2024: Annals of Hematology
https://read.qxmd.com/read/38629577/co-transplantation-of-autologous-treg-cells-a-groundbreaking-cell-therapy-for-brain-diseases
#25
JOURNAL ARTICLE
Yue Cheng, Yueman Zhang, Peiying Li
Cell therapy and regenerative medicine have made remarkable progress in treating neurodegenerative disorders. Induced pluripotent stem cells (iPSCs) offer a promising source for cell replacement therapies, but their practical application faces challenges due to poor survival and integration after transplantation. Park et al. propose a novel therapeutic strategy involving the co-transplantation of regulatory T cells (Tregs) and iPSC-derived dopamine neurons. This combined approach enhances the survival of transplanted cells and protects against neuroinflammation-induced damage...
April 17, 2024: Journal of Cerebral Blood Flow and Metabolism
https://read.qxmd.com/read/38629252/entrapment-of-the-subscapular-artery-between-the-radial-nerve-and-the-posterior-wall-of-the-axilla-an-anatomical-variation-with-clinical-significance
#26
JOURNAL ARTICLE
Dimitra Daskalopoulou, Dimosthenis Chrysikos, Alexandros Samolis, George Tsakotos, Amir Shihada, Maria Piagkou, Theodore Troupis
OBJECTIVE: The subscapular artery vascularizes a substantial region of the thoracic wall, and the significance of its distribution is well depicted in the diversity of reconstructive procedures that rely on its blood supply. The aim of this study is to present an uncommon anatomical variation of the artery and discuss the clinical implications of its presence. CASE REPORT: This case report depicts a rare variant of compression and the kinking of the subscapular artery by the radial nerve on the posterior wall of the axilla that was encountered during dissection of a male cadaver of Greek origin...
March 25, 2024: Acta Medica Academica
https://read.qxmd.com/read/38628661/a-prospective-analysis-of-the-efficacy-of-phase-ii-autologous-skin-grafting-on-deep-second%C3%A2-degree-burns-on-the-dorsum-of-the-hand
#27
JOURNAL ARTICLE
Jing'en Sun, Siman Su, Songsong Jiao, Gang Li, Zhi Zhang, Weihua Lin, Shuyao Zhang
The aim of the present study was to investigate the possibility of reducing the damage to the donor site while preserving the functional recovery of the dorsum of the hand following burn injury. An attempt was made to analyze the effect of a phased surgery approach on inflammatory indicators. A two-phase treatment was administered on a total of 64 patients with deep second-degree burns on the dorsum of the hand who were admitted to Guangzhou Red Cross Hospital between January 2020 and March 2023. During phase I treatment, the wounds were covered with xenogeneic (porcine) skin, followed by the application of autologous thin intermediate thickness skin grafts for wound repair in phase II treatment 1 week later...
May 2024: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/38626745/prognostic-implications-of-circulating-plasma-cell-percentage-in-multiple-myeloma-and-primary-plasma-cell-leukemia-defined-by-new-criteria
#28
JOURNAL ARTICLE
Xianghong Jin, Xianyong Jiang, Hui Li, Kaini Shen, Shuangjiao Liu, Miao Chen, Chen Yang, Bing Han, Junling Zhuang
INTRODUCTION: The definition of primary plasma cell leukemia (pPCL) has been revised from ≥20% to ≥5% circulating plasma cells (CPC). However, the precise prognosis associated with CPC remains controversial. This study aimed to investigate prognostic biomarkers for myeloma patients based on CPC presence. METHODS: A comprehensive analysis was conducted on 309 consecutive patients diagnosed with either multiple myeloma or pPCL, utilizing peripheral blood smears stained with Wright-Giemsa...
April 16, 2024: Acta Haematologica
https://read.qxmd.com/read/38623681/a-case-of-blastic-plasmacytoid-dendritic-cell-neoplasm-with-orbital-tumor-as-the-initial-symptom
#29
Peizhang Li, Naiqi Pang, Meiqin Li, Juan Xie, Ying Wang
BACKGROUND: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy arising from precursor dendritic cells. It is a rare and challenging clinical presentation. For decades, there has been no treatment course for managing BPDCN and its overall prognosis is poor. METHODS AND RESULTS: We report a 27-year-old man who was admitted to the hospital due to an orbital tumor as the first symptom. Progressive enlargement of the orbital tumor was accompanied by multiple purple circular nodules on the body trunk...
April 1, 2024: Clinical Laboratory
https://read.qxmd.com/read/38623445/impact-of-gabapentin-on-postoperative-hypotension-in-enhanced-recovery-after-surgery-protocols-for-microvascular-breast-reconstruction
#30
JOURNAL ARTICLE
Corbin E Muetterties, Jeremiah M Taylor, Diana E Kaeding, Ricardo Rosales Morales, Anissa V Nguyen, Lorna Kwan, Charles Y Tseng, Michael R Delong, Jaco H Festekjian
BACKGROUND: Enhanced recovery after surgery (ERAS) protocols have been associated with hypotensive episodes after autologous breast reconstruction. Gabapentin (Gaba), a nonopioid analgesic used in ERAS, has been shown to attenuate postoperative hemodynamic responses. This study assesses ERAS's impact, with and without Gaba, on postoperative hypotension after microvascular breast reconstruction. METHODS: Three cohorts were studied: traditional pathway, ERAS + Gaba, and ERAS no-Gaba...
April 2024: Plastic and Reconstructive Surgery. Global Open
https://read.qxmd.com/read/38621748/tumor-organoids-the-era-of-personalized-medicine
#31
REVIEW
Natalia V Rassomakhina, Alexandra Yu Ryazanova, Astemir R Likhov, Sergey A Bruskin, Liliya G Maloshenok, Victoria V Zherdeva
The strategies of future medicine are aimed to modernize and integrate quality approaches including early molecular-genetic profiling, identification of new therapeutic targets and adapting design for clinical trials, personalized drug screening (PDS) to help predict and individualize patient treatment regimens. In the past decade, organoid models have emerged as an innovative in vitro platform with the potential to realize the concept of patient-centered medicine. Organoids are spatially restricted three-dimensional clusters of cells ex vivo that self-organize into complex functional structures through genetically programmed determination, which is crucial for reconstructing the architecture of the primary tissue and organs...
January 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38616321/tracking-fat-grafts-by-magnetic-resonance-imaging-a-comparative-study-of-adolescent-and-adult-patients-with-stable-localized-scleroderma
#32
JOURNAL ARTICLE
Xuda Ma, Liquan Wang, Tianhao Li, Ziming Li, Yu Chen, Tianjiao Wang, Xiao Long, Jiuzuo Huang, Xiaojun Wang
BACKGROUND: The optimal timing of reconstruction for patients with facial localized scleroderma is uncertain. The purpose of this study was to compare the outcomes of autologous fat transplantation in adolescent and adult patients with stable localized scleroderma. METHODS: Adolescent (age 10-19 years) and adult (age >19 years) patients with no previous surgery were enrolled (n = 10, each group). Preoperative magnetic resonance imaging (MRI), blood tests and dermatological assessments were used for disease activity assessment...
April 15, 2024: Plastic and Reconstructive Surgery
https://read.qxmd.com/read/38615378/combination-of-chidamide-and-pd-1-blockade-in-refractory-relapsed-aggressive-large-b-cell-lymphomas-with-high-risk-of-failing-car-t-therapy
#33
JOURNAL ARTICLE
Zhenhao Wang, Hao Xu, Yu Mei, Min Xiao, Yang Cao, Liang Huang, Zhuming Yang, Yicheng Zhang, Zhiqiang Han, Miao Zheng, Zhenya Hong
BACKGROUND: Refractoriness and relapse after chimeric antigen receptor T-cell therapy have emerged as major challenges for immunotherapy of aggressive large B-cell lymphoma. Thus far, there is no consensus on how to address treatment failure and whether to administer maintenance therapy following CAR-T cell therapy. METHODS: From August 2017 through November 2022, 52 patients with refractory/relapsed aggressive LBCL who had a high risk of resistance to CAR-T cell therapy were given chidamide in combination with a PD-1 inhibitor as maintenance therapy following either CAR19/22 T-cell cocktail therapy or CAR19/22 T-cell cocktail therapy plus autologous stem cell transplantation (ASCT)...
April 13, 2024: International Immunopharmacology
https://read.qxmd.com/read/38613810/activating-transcription-factor-6-alleviates-secondary-brain-injury-by-increasing-cystathionine-%C3%AE-lyase-expression-in-a-rat-model-of-intracerebral-hemorrhage
#34
JOURNAL ARTICLE
Tianyu Liang, Sen Xu, Renyang Liu, Xiaoping Xia
BACKGROUND: Intracerebral hemorrhage (ICH) comprises primary and secondary injuries, the latter of which induces increased inflammation and apoptosis and is more severe. Activating transcription factor 6 (ATF6) is a type-II transmembrane protein in the endoplasmic reticulum (ER). ATF6 target genes could improve ER homeostasis, which contributes to cryoprotection. Hence, we predict that ATF6 will have a protective effect on brain tissue after ICH. METHOD: The ICH rat model was generated through autologous blood injection into the right basal ganglia, the expression of ATF6 after ICH was determined by WB and IF...
April 10, 2024: Aging
https://read.qxmd.com/read/38613464/special-issue-abstracts-from-the-american-society-for-apheresis-45th-annual-meeting-april-17-19-2024
#35
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2024: Journal of Clinical Apheresis
https://read.qxmd.com/read/38612407/mrna-lnp-covid-19-vaccine-lipids-induce-complement-activation-and-production-of-proinflammatory-cytokines-mechanisms-effects-of-complement-inhibitors-and-relevance-to-adverse-reactions
#36
JOURNAL ARTICLE
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, Petra Berényi, Réka Facskó, Henriette Farkas, László Dézsi, Carlo Heirman, Stefaan de Koker, Raymond Schiffelers, Kathryn Anne Glatter, Tamás Radovits, Gábor Szénási, János Szebeni
A small fraction of people vaccinated with mRNA-lipid nanoparticle (mRNA-LNP)-based COVID-19 vaccines display acute or subacute inflammatory symptoms whose mechanism has not been clarified to date. To better understand the molecular mechanism of these adverse events (AEs), here, we analyzed in vitro the vaccine-induced induction and interrelations of the following two major inflammatory processes: complement (C) activation and release of proinflammatory cytokines. Incubation of Pfizer-BioNTech's Comirnaty and Moderna's Spikevax with 75% human serum led to significant increases in C5a, sC5b-9, and Bb but not C4d, indicating C activation mainly via the alternative pathway...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38609316/phase-1-study-combining-elotuzumab-with-autologous-stem-cell-transplant-and-lenalidomide-for-multiple-myeloma
#37
JOURNAL ARTICLE
David G Coffey, Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal, Donna Catamero, Seunghee Kim-Schulze, Sacha Gnjatic, Ajai Chari, Samir Parekh, Sundar Jagannath, Hearn Jay Cho
BACKGROUND: Autologous stem cell transplantation (ASCT) after induction therapy improves disease-free survival for patients with multiple myeloma (MM). While the goal of ASCT is to render a minimal disease state, it is also associated with eradication of immunosuppressive cells, and we hypothesize that early introduction of immunotherapy post-ASCT may provide a window of opportunity to boost treatment efficacy. METHODS: We conducted a phase 1 clinical trial to investigate the application of autologous lymphocyte infusion and anti-SLAMF7 monoclonal antibody, elotuzumab, after ASCT in patients with newly diagnosed MM previously treated with induction therapy...
April 12, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38604813/autologous-human-preclinical-modeling-of-melanoma-interpatient-clinical-responses-to-immunotherapeutics
#38
JOURNAL ARTICLE
Yee Peng Phoon, Jared E Lopes, Lukas W Pfannenstiel, Claudia Marcela Diaz-Montero, Ye F Tian, Marc S Ernstoff, Pauline Funchain, Jennifer S Ko, Raymond Winquist, Heather C Losey, Jan Joseph Melenhorst, Brian R Gastman
BACKGROUND: Despite recent advances in immunotherapy, a substantial population of late-stage melanoma patients still fail to achieve sustained clinical benefit. Lack of translational preclinical models continues to be a major challenge in the field of immunotherapy; thus, more optimized translational models could strongly influence clinical trial development. To address this unmet need, we designed a preclinical model reflecting the heterogeneity in melanoma patients' clinical responses that can be used to evaluate novel immunotherapies and synergistic combinatorial treatment strategies...
April 11, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38603613/sildenafil-improves-hemodynamic-changes-caused-by-acute-pulmonary-embolism-by-inhibiting-rho-kinase-activity
#39
JOURNAL ARTICLE
Hui Wang, Wei Li, Yan Yan, Meng-Jie Shi, Feng Hou, Rui-Peng Zhang
OBJECTIVE: This study examined the effects of sildenafil on acute pulmonary embolism (APE) using a rat model. METHODS: Sprague-Dawley rats were randomly divided into the sham, pulmonary thromboembolism (PTE), and sildenafil groups. The sham and PTE groups received normal saline once daily via gavage for 14 consecutive days, whereas the sildenafil group received sildenafil (0.5 mg/kg/day) once daily via gavage for 14 consecutive days. Autologous emboli were prepared from blood samples collected from the left femoral artery of rats in each group on day 13, and autologous emboli were injected into the jugular vein cannula of rats in the PTE and sildenafil groups on day 14...
April 2024: Journal of International Medical Research
https://read.qxmd.com/read/38601242/comparison-of-autologous-blood-injection-and-dextrose-prolotherapy-in-the-treatment-of-chronic-recurrent-temporomandibular-dislocation-a-randomized-clinical-trial
#40
JOURNAL ARTICLE
Ashwini Chhapane, Kavita Wadde, Sanpreet Singh Sachdev, Swapnil Barai, Jayant Landge, Maroti Wadewale
INTRODUCTION: Prolotherapy is a minimally invasive technique that aims to functionally restore or repair the soft and hard tissues of the TMJ by injecting a stimulant. The present study was conducted to compare the effectiveness of dextrose and autologous blood injection (ABI) as prolotherapy agents in the treatment of patients with chronic recurrent TMJ dislocation (CRTD). MATERIALS AND METHOD: Thirty-two patients were divided into two groups-ABI and dextrose ( n  = 16 each)...
April 2024: Journal of Maxillofacial and Oral Surgery
keyword
keyword
71228
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.